One-click collection: Consensus on the January/February updated guidelines for urological neoplasms/diseases

2022-08-21 0 By

This article summarizes the latest domestic and foreign guidelines and consensus on urinary diseases/urinary tumors released in January and February for your reference and download.In February 2022, the European Society of Urology (EAU) published guidelines for the management of non-neurogenic lower urinary tract symptoms in women. Part 2 of the guidelines covers the management of bladder insufficiency, bladder outlet obstruction, and nocturia.Download link: ERKNet consensus: fetal definition, diagnosis and management of urinary tract obstruction in February 2022, the European rare nephropathy reference network consensus (ERKNet) showed:Fetal lower urinary tract obstruction (LUTO) is associated with higher mortality and postnatal morbidity due to pulmonary hypoplasia and impaired renal function.This article provides consensus recommendations on the clinical definition, diagnosis, and management of LUTO for prenatal testing.Download link: 2021 EULIS and IAU joint expert consensus:Soft ureteroscopic lithotripsy (RIRS) is one of the main treatment methods for kidney stones, which has the advantages of accuracy, effectiveness, safety and rapid recovery.In November 2021, the Urolithiasis Branch of the European Society of Urology (EULIS) and the International Urolithiasis Union (IAU) jointly issued a consensus on the treatment of soft ureteroscopic lithotripsy for kidney stones, mainly reaching a consensus on perioperative management, surgical techniques and postoperative follow-up.In order to better promote and standardize the clinical application of RIRS, this paper interprets its relevant core content.Download links: CUA guidelines: renal small lumps (full) in February 2022, the Canadian association of urology (CUA) released a small renal mass administration guide.The incidence of small renal mass (SRM) is increasing worldwide, mainly due to the increasing availability of abdominal imaging.The main objective of this study is to provide evidence-based guidance for the evaluation and management of small renal masses.Download link: SIAMS position statement: the management of male factor infertility in January 2022, the Italian male and sexual medicine association (SIAMS) released a statement file management of male factor infertility.About 15-20% of couples are infertile, and in half of those cases there is a male component.There is no consensus on the diagnosis and treatment of male factor infertility in many aspects. This paper mainly provides guidance for the management of male factor infertility.Download link: China outpatient service process guidance premature ejaculation (PE) in patients with premature ejaculation is one of the most common male sexual dysfunction, the pathogenic mechanism of complex and the relative lack of treatment method, and curative effect of some uncertainty to male urological or sexual medicine physicians was tricky.Therefore, the Chinese Society of Sexology took the lead in developing the Outpatient Procedure Guide for Patients with premature ejaculation in China, aiming to standardize the PE outpatient procedure and improve the PE diagnosis and treatment effect through standardized and standardized diagnosis and treatment paths.Download link: urinary tumor 2022 multi-disciplinary consensus:Prevention and treatment of osteoporosis and brittle fractures in men with prostate cancer Androgen deprivation therapy (ADT) Men with prostate cancer (PCa) are at high risk for osteoporosis and brittle fractures.This article mainly provides consensus guidance for the prevention and treatment of osteoporosis and brittle fracture in these patients.Download link: (clinical practice guidelines:In February 2022, the Ontario Cancer Treatment Centre (CCO) published guidelines for the diagnosis of clinically significant prostate cancer by multiparameter magnetic resonance imaging. This paper is based on a series of systematic reviews.To evaluate multiparameter magnetic resonance imaging (mpMRI) in the diagnosis of clinically significant prostate cancer.Download link: prostate cancer screening and early detection of China (2022, Beijing) prostate cancer treated early guide is occurs in elderly male reproductive system malignant tumor.Screening high-risk population and early diagnosis and early treatment are very important to improve the cure rate of prostate cancer.The formulation of guidelines for prostate cancer screening, early diagnosis and early treatment in accordance with China’s national conditions will promote the homogeneity and standardization of prostate cancer screening in China, and improve the effectiveness of prostate cancer screening.Prostate cancer screening and early detection in China treated early guide (2022, Beijing) entrusted by national commission on health bureau of disease prevention and control and guidance, initiated by the national cancer center, combined multi-disciplinary experts, according to the world health organization’s guidelines for manual principles and methods of integration in prostate cancer screening and early detection treated early at home and abroad in recent years, the new progress ofTaking into account the practical experience of prostate cancer screening in China, detailed evidence-based recommendations were made on 15 key issues such as screening objects, technologies, procedures and quality control, aiming to standardize the practice of prostate cancer screening, early diagnosis and early treatment, and improve the prevention and control effect of prostate cancer in China.Download link: after the bladder into the road robot assisted radical prostatectomy China expert consensus (2021 edition) the incidence of prostate cancer in the world occupies the second place of men of malignant tumor, which also showed a trend of rapid rise in our country.A number of medical centers in China have formulated expert consensus on the implementation of robot-assisted radical prostatectomy through cystoid approach based on the experience of our unit in carrying out robot-assisted radical prostatectomy through cystoid approach, combined with the latest international theory and experience of surgical treatment of prostate cancer.Download link: China renal tumor laparoscopic partial nephrectomy and robot expert consensus renal cell carcinoma is a common urinary tract tumor, renal resection (partial nephrectomy, PN) is one of the main methods for the treatment of renal cancer.According to the application status of laparoscopic and robotic partial nephrectomy in China, combined with the latest theories and practices at home and abroad, the minimally invasive Group of Urogenital Tumor Professional Committee of The Chinese Anti-Cancer Association formulated expert consensus on laparoscopic and robotic partial nephrectomy for renal tumor in China after extensive discussion by experts.In order to provide theoretical basis for the standardized application of PN in the treatment of patients with renal tumor.Download link: